Could acetaminophen replace opioids for kidney stone pain?
NCT ID NCT07368738
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a combination of IV acetaminophen and ketorolac can manage pain during kidney stone shockwave treatment as well as the standard opioid-based regimen. About 266 adults will be randomly assigned to receive either the non-opioid or opioid pain medicines. The goal is to see if the non-opioid approach provides similar pain control with fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- acetaminophen and ketorolac
- What this could lead to
- If it works, this could offer a safer, non-opioid option for managing pain during kidney stone procedures.
- What could go wrong
- This is a small, early-phase trial, so results may not apply to all patients. The non-opioid regimen might not control pain as well as opioids.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 266 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 19 years * Undergoing ESWL * Able to provide informed consent Exclusion Criteria: * Prior ESWL treatment in the past six months * Narcotic use in the last 48 hours * Allergy to midazolam, fentanyl, acetaminophen, or ketorolac * Chronic kidney disease * Solitary kidney * Active peptic ulcer disease * Concurrent anticoagulant prescription * Liver disease * Elevated liver function tests * Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Extracorporeal shockwave lithotripsy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
St. Joseph's Hospital
Saint John, New Brunswick, E2L 3L6, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single drug dose curb opioid side effects after kidney stone surgery?
- Can a thinner scope make kidney stone surgery easier and cheaper?
- Which kidney stone surgery causes more Pre-Op worry?
- Which procedure wins for dense kidney stones?
- Can a phosphate binder curb kidney stone risk?
- Can medical glue replace the drainage tube in kidney stone surgery?